Meitav Dash Investments LTD Hepion Pharmaceuticals, Inc. Transaction History

Meitav Dash Investments LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 03, 2021	SELL	$1.39 - $2.1 $69,500 - $105,000	-50,000 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$1.56 - $2.26 $9,360 - $13,559	6,000 Added 13.64%	50,000 $99,000
Q1 2021 May 06, 2021	BUY	$1.77 - $2.98 $77,880 - $131,120	44,000 New	44,000 $81,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $57.2M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

Stay updated on Meitav Dash Investments LTD with notifications on news.